Back to search

Article

Uptake, effectiveness and safety of COVID-19 vaccines in the immunocompromised population: A population-based cohort study in England

2023-09-14

Abstract excerpt

<title>Abstract</title> <p>Immunocompromised individuals face increased risks of severe COVID-19 outcomes, underscoring the importance of receiving COVID-19 vaccination. However, there's a lack of comprehensive real-world data on their COVID-19 vaccine uptake, effectiveness, and safety profile. We analysed data in the QResearch UK database from 01/12/2020 to 11/04/2022. We included 12,274,948 people aged ≥ 12 yea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d214c645-850b-59bc-b1ff-b05984c5769e
DOI
10.21203/rs.3.rs-3316645/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Uptake, effectiveness and safety of COVID-19 vaccines in the immunocompromised population: A population-based cohort study in EnglandDOI 10.21203/rs.3.rs-3316645/v1
Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in ScotlandSemantic proximity
Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in FranceSemantic proximity
Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalisation and death in the post vaccination era: A systematic review.Semantic proximity
Immunogenicity of COVID-19 mRNA Vaccines in Immunocompromised Patients: A Systematic Review and Meta-AnalysisSemantic proximity
Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021Semantic proximity
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A Systematic Literature ReviewSemantic proximity
Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity
Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity
Clinical and Economic impact of updated Fall 2023 COVID-19 vaccines in the Immunocompromised Population in CanadaSemantic proximity
Unveiling Protection: A Meta-Analysis of Tixagevimab-Cilgavimab Prophylaxis in 28,950 Transplant Recipients and Immunocompromised Patients Against COVID-19Semantic proximity
Rates of COVID-19-Associated Hospitalization in Immunocompromised Individuals in Omicron-era: A Population-Based Observational Study Using Surveillance Data in British Columbia, CanadaSemantic proximity
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELYSemantic proximity
Select a neighboring publication to make it the new centre.